Argeris N. Karabelas, Director at Vanda Pharmaceuticals Inc. (VNDA), sold 228,924 shares at $11.03 ($2.5M) on 2009-12-15, disclosed to the SEC on 2009-12-16.
Open-market sale of $2.5M VNDA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.14 | 130,000 | $1.4M | 57.0% |
| 2 | $11.03 | 98,924 | $1.1M | 43.0% |
| Total | $11.09 avg | 228,924 | $2.5M | 100% |
| Filing → |
| RGNX | SELL | 2024-08-05 | $136K | — | Filing → |
| RGNX | SELL | 2024-07-30 | $166K | — | Filing → |
| RGNX | SELL | 2024-07-03 | $113K | — | Filing → |